Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Sitagliptin in Individuals With Genetically Decreased DPP4

NCT04323189 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT04323189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04323189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Sitagliptin in Individuals With Genetically Decreased DPP4
Lead sponsor
University of Pennsylvania
Phase
Phase 4
Overall status
Active, not recruiting
Start date
August 26, 2020
Completion date
February 28, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

genetics disease, heart failure, type2 diabetes